Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines (Q47896407)

6 February 2018

title

Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines (English)

1 reference

6 February 2018

main subject

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

Nontombi Mbelle

5

0 references

Mark Nicol

object named as

Mark Nicol

2

0 references

Keith P. Klugman

7

object named as

Keith P Klugman

1 reference

6 February 2018

4

Helena Käyhty

1 reference

6 February 2018

author name string

Robin E Huebner

1

1 reference

6 February 2018

Rosalia Mothupi

3

1 reference

6 February 2018

Esther Khomo

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 December 2004

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

23

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

802-806

1 reference

6 February 2018

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.06.052

10.1016/J.VACCINE.2004.06.052

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018